-
1
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myo-cardial infarction, and stroke in high risk patients
-
Antithrombotic Trialists Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myo-cardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
2
-
-
0030021512
-
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia
-
Algra A, van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry. 1996; 60:197-199.
-
(1996)
J Neurol Neurosurg Psychiatry
, vol.60
, pp. 197-199
-
-
Algra, A.1
Van Gijn, J.2
-
3
-
-
0030297319
-
European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
-
Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1-13.
-
(1996)
J Neurol Sci
, vol.143
, pp. 1-13
-
-
Diener, H.C.1
Cunha, L.2
Forbes, C.3
Sivenius, J.4
Smets, P.5
Lowenthal, A.6
-
4
-
-
0030590746
-
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
-
Caprie Steering Committee
-
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339
-
(1996)
Lancet
, vol.348
, pp. 1329-1339
-
-
-
5
-
-
33646596912
-
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial
-
The ESPRIT Study Group
-
The ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet. 2006;367:1665-1673.
-
(2006)
Lancet
, vol.367
, pp. 1665-1673
-
-
-
6
-
-
33645861080
-
For the CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
-
Bhatt DL, Fox KAA, Werner Hacke CB, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Claiborne Johnston S, Mak K-H, Mas J-L, Montalescot G, Pearson TA, Steg PGD, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ, for the CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706-1717.
-
(2006)
N Engl J Med
, vol.354
, pp. 1706-1717
-
-
Bhatt, D.L.1
Fox, K.A.A.2
Werner Hacke, C.B.3
Berger, P.B.4
Black, H.R.5
Boden, W.E.6
Cacoub, P.7
Cohen, E.A.8
Creager, M.A.9
Easton, J.D.10
Flather, M.D.11
Haffner, S.M.12
Hamm, C.W.13
Hankey, G.J.14
Claiborne, J.15
Ohnston, S.16
Mak, K.-H.17
Mas, J.-L.18
Montalescot, G.19
Pearson, T.A.20
Steg, P.G.D.21
Steinhubl, S.R.22
Weber, M.A.23
Brennan, D.M.24
Fabry-Ribaudo, L.25
Booth, J.26
Topol, E.J.27
more..
-
7
-
-
3242770664
-
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial
-
Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331-337
-
(2004)
Lancet
, vol.364
, pp. 331-337
-
-
Diener, H.C.1
Bogousslavsky, J.2
Brass, L.M.3
Cimminiello, C.4
Csiba, L.5
Kaste, M.6
Leys, D.7
Matias-Guiu, J.8
Rupprecht, H.J.9
-
8
-
-
0030911057
-
The International Stroke Trial (IST); A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke
-
International Stroke Trial Collaborative Group
-
International Stroke Trial Collaborative Group. The International Stroke Trial (IST); a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997; 349:1569-1581.
-
(1997)
Lancet
, vol.349
, pp. 1569-1581
-
-
-
9
-
-
0030985284
-
CAST: Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke
-
CAST (Chinese Acute Stroke Trial) Collaborative Group.
-
CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997;349:1641-1649.
-
(1997)
Lancet
, vol.349
, pp. 1641-1649
-
-
-
10
-
-
35248821708
-
Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): A randomised controlled pilot trial
-
for the FASTER Investigators
-
Kennedy J, Hill MD, Ryckborst K, Elliaziw M, Demchuk MAM, Buchan AM, for the FASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6:961-969.
-
(2007)
Lancet Neurol
, vol.6
, pp. 961-969
-
-
Kennedy, J.1
Hill, M.D.2
Ryckborst, K.3
Elliaziw, M.4
Demchuk, M.A.M.5
Buchan, A.M.6
-
11
-
-
34147143086
-
Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: The prevention regimen for effectively avoiding second strokes trial (PRoFESS)
-
for the Steering Committee and PRoFESS Study Group
-
Diener H-C, Sacco RL, Yusuf S, for the Steering Committee and PRoFESS Study Group. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the prevention regimen for effectively avoiding second strokes trial (PRoFESS). Cerebrovasc Dis. 2007;23:368-380.
-
(2007)
Cerebrovasc Dis
, vol.23
, pp. 368-380
-
-
Diener, H.-C.1
Sacco, R.L.2
Yusuf, S.3
-
12
-
-
51449116270
-
The PROFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
-
Sacco RL, Diener H-C, Yusuf S, Cotton D, Ounpuu S, Lawton W, Palesch Y, Martin R, Albers GW, Bath PM, Bornstein N, Chan BPL, Chen S-T, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick PB, Gu V, Hermansson K, Hillbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voight T, Weber M, Yoon B-W, the PROFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238-1251.
-
(2008)
N Engl J Med
, vol.359
, pp. 1238-1251
-
-
Sacco, R.L.1
Diener, H.-C.2
Yusuf, S.3
Cotton, D.4
Ounpuu, S.5
Lawton, W.6
Palesch, Y.7
Martin, R.8
Albers, G.W.9
Bath, P.M.10
Bornstein, N.11
Chan, B.P.L.12
Chen, S.-T.13
Cunha, L.14
Dahlof, B.15
De Keyser, J.16
Donnan, G.A.17
Estol, C.18
Gorelick, P.B.19
Gu, V.20
Hermansson, K.21
Hillbrich, L.22
Kaste, M.23
Lu, C.24
MacHnig, T.25
Pais, P.26
Roberts, R.27
Skvortsova, V.28
Teal, P.29
Toni, D.30
Vandermaelen, C.31
Voight, T.32
Weber, M.33
Yoon, B.-W.34
more..
-
13
-
-
52249116778
-
For the PROFESS Study Group. Telm-isartan to prevent recurrent stroke and cardiovascular events
-
Yusuf S, Diener H-C, Sacco RL, Cotton D, Ounpuu S, Lawson WA, Palesch Y, Martin RH, Albers GW, Bath PM, Bornstein N, Chan BPL, Chen S-T, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick PB, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig G, PP, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voight T, Weber M, Yoon B-W, for the PROFESS Study Group. Telm-isartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008;359:1225-1237.
-
(2008)
N Engl J Med
, vol.359
, pp. 1225-1237
-
-
Yusuf, S.1
Diener, H.-C.2
Sacco, R.L.3
Cotton, D.4
Ounpuu, S.5
Lawson, W.A.6
Palesch, Y.7
Martin, R.H.8
Albers, G.W.9
Bath, P.M.10
Bornstein, N.11
Chan, B.P.L.12
Chen, S.-T.13
Cunha, L.14
Dahlof, B.15
De Keyser, J.16
Donnan, G.A.17
Estol, C.18
Gorelick, P.B.19
Gu, V.20
Hermansson, K.21
Hilbrich, L.22
Kaste, M.23
Lu, C.24
MacHnig, G.25
Pp Roberts, R.26
Skvortsova, V.27
Teal, P.28
Toni, D.29
Vandermaelen, C.30
Voight, T.31
Weber, M.32
Yoon, B.-W.33
more..
-
14
-
-
51449085994
-
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telm-isartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: A double-blind, active and placebo-controlled study
-
for the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group
-
Diener H-C, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton W, Palesch Y, Martin R, Albers GW, Bath PM, Bornstein N, Chan BPL, Chen S-T, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick PB, Gu V, Hermansson K, Hillbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voight T, Weber M, Yoon B-W, for the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telm-isartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008;7:875-884.
-
(2008)
Lancet Neurol
, vol.7
, pp. 875-884
-
-
Diener, H.-C.1
Sacco, R.L.2
Yusuf, S.3
Cotton, D.4
Ounpuu, S.5
Lawton, W.6
Palesch, Y.7
Martin, R.8
Albers, G.W.9
Bath, P.M.10
Bornstein, N.11
Chan, B.P.L.12
Chen, S.-T.13
Cunha, L.14
Dahlof, B.15
De Keyser, J.16
Donnan, G.A.17
Estol, C.18
Gorelick, P.B.19
Gu, V.20
Hermansson, K.21
Hillbrich, L.22
Kaste, M.23
Lu, C.24
MacHnig, T.25
Pais, P.26
Roberts, R.27
Skvortsova, V.28
Teal, P.29
Toni, D.30
Vandermaelen, C.31
Voight, T.32
Weber, M.33
Yoon, B.-W.34
more..
-
15
-
-
70350561899
-
Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: A PRoFESS subgroup analysis
-
Bath PM, Martin RH, Palesch Y, Cotton D, Yusuf S, Sacco R, Diener HC, Toni D, Estol C, Roberts R; PRoFESS Study Group. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke. 2009; 40:3541-3546
-
(2009)
Stroke
, vol.40
, pp. 3541-3546
-
-
Bath, P.M.1
Martin, R.H.2
Palesch, Y.3
Cotton, D.4
Yusuf, S.5
Sacco, R.6
Diener, H.C.7
Toni, D.8
Estol, C.9
Roberts, R.10
Profess Study, Group.11
-
16
-
-
34249829251
-
The Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? statistical re-analysis of functional outcomes in stroke trials
-
The Optimising Analysis of Stroke Trials (OAST) Collaboration. Can we improve the statistical analysis of stroke trials? statistical re-analysis of functional outcomes in stroke trials. Stroke. 2007;38:1911-1915.
-
(2007)
Stroke
, vol.38
, pp. 1911-1915
-
-
-
17
-
-
54049099977
-
Use of ordinal outcomes in vascular prevention trials: Comparison with binary outcomes in published stroke trials
-
Bath PMW, Geeganage CM, Gray LJ, Collier T, Pocock S. Use of ordinal outcomes in vascular prevention trials: comparison with binary outcomes in published stroke trials. Stroke. 2008;39:2817-2823.
-
(2008)
Stroke
, vol.39
, pp. 2817-2823
-
-
Bath, P.M.W.1
Geeganage, C.M.2
Gray, L.J.3
Collier, T.4
Pocock, S.5
-
18
-
-
0023472546
-
European stroke prevention study: Principle end points
-
European Stroke Prevention Study Group (ESPS)
-
European Stroke Prevention Study Group (ESPS). European stroke prevention study: principle end points. Lancet. 1987;2:1351-1354.
-
(1987)
Lancet
, vol.2
, pp. 1351-1354
-
-
-
19
-
-
51349157097
-
A randomised controlled trial of triplet antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: Safety, tolerability and feasibility
-
Sprigg N, Gray LJ, England T, Willmot MR, Zhao L, Sare GM, Bath PMW. A randomised controlled trial of triplet antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility. PloS One. 2008;3:e2852.
-
(2008)
PloS One
, vol.3
-
-
Sprigg, N.1
Gray, L.J.2
England, T.3
Willmot, M.R.4
Zhao, L.5
Sare, G.M.6
Bath, P.M.W.7
-
20
-
-
18244404294
-
Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection; The clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial
-
Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, Ringelstein EB. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection; the clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation. 2005;111: 2233-2240.
-
(2005)
Circulation
, vol.111
, pp. 2233-2240
-
-
Markus, H.S.1
Droste, D.W.2
Kaps, M.3
Larrue, V.4
Lees, K.R.5
Siebler, M.6
Ringelstein, E.B.7
|